Abdala, The administration of a third dose of candidate vaccine Abdala, as part of phase III clinical trials, has been completed and efficacy studies begin

Anti-COVID-19 vaccine candidate by the name of Abdala, to primary and secondary line health workers, the intervention study in this at-risk population began on April 1st in the municipality of Santiago de Cuba in the province of the same name.

The Lancet. alha Burki- Cuba’s long-standing commitment to health has led to a successful COVID-19 pandemic response, but it is threatened by financial and supplier issues.